Nirmatrelvir–remdesivir association for non-hospitalized adults with COVID-19, point of view

The efforts of the scientific world directed to identifying new antiviral drugs and therapies effective against SARS-CoV-2 continue. New oral antivirals against SARS-CoV-2 such as paxlovid have recently authorized. Evidence shows that these antivirals have good efficacy in reducing the risk of hospi...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferrara, Francesco, Zovi, Andrea, Trama, Ugo, Vitiello, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9386652/
https://www.ncbi.nlm.nih.gov/pubmed/35980509
http://dx.doi.org/10.1007/s10787-022-01055-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9386652/
https://www.ncbi.nlm.nih.gov/pubmed/35980509
http://dx.doi.org/10.1007/s10787-022-01055-2

Ejemplares similares